» Articles » PMID: 38227517

Post-transcriptional Mechanisms Controlling Neurogenesis and Direct Neuronal Reprogramming

Overview
Date 2024 Jan 16
PMID 38227517
Authors
Affiliations
Soon will be listed here.
Abstract

Neurogenesis is a tightly regulated process in time and space both in the developing embryo and in adult neurogenic niches. A drastic change in the transcriptome and proteome of radial glial cells or neural stem cells towards the neuronal state is achieved due to sophisticated mechanisms of epigenetic, transcriptional, and post-transcriptional regulation. Understanding these neurogenic mechanisms is of major importance, not only for shedding light on very complex and crucial developmental processes, but also for the identification of putative reprogramming factors, that harbor hierarchically central regulatory roles in the course of neurogenesis and bare thus the capacity to drive direct reprogramming towards the neuronal fate. The major transcriptional programs that orchestrate the neurogenic process have been the focus of research for many years and key neurogenic transcription factors, as well as repressor complexes, have been identified and employed in direct reprogramming protocols to convert non-neuronal cells, into functional neurons. The post-transcriptional regulation of gene expression during nervous system development has emerged as another important and intricate regulatory layer, strongly contributing to the complexity of the mechanisms controlling neurogenesis and neuronal function. In particular, recent advances are highlighting the importance of specific RNA binding proteins that control major steps of mRNA life cycle during neurogenesis, such as alternative splicing, polyadenylation, stability, and translation. Apart from the RNA binding proteins, microRNAs, a class of small non-coding RNAs that block the translation of their target mRNAs, have also been shown to play crucial roles in all the stages of the neurogenic process, from neural stem/progenitor cell proliferation, neuronal differentiation and migration, to functional maturation. Here, we provide an overview of the most prominent post-transcriptional mechanisms mediated by RNA binding proteins and microRNAs during the neurogenic process, giving particular emphasis on the interplay of specific RNA binding proteins with neurogenic microRNAs. Taking under consideration that the molecular mechanisms of neurogenesis exert high similarity to the ones driving direct neuronal reprogramming, we also discuss the current advances in in vitro and in vivo direct neuronal reprogramming approaches that have employed microRNAs or RNA binding proteins as reprogramming factors, highlighting the so far known mechanisms of their reprogramming action.

Citing Articles

The Hippo effector TEAD1 regulates postnatal murine cerebellar development.

Atterton C, Pelenyi A, Jones J, Currey L, Al-Khalily M, Wright L Brain Struct Funct. 2025; 230(3):42.

PMID: 40064689 PMC: 11893647. DOI: 10.1007/s00429-025-02903-x.


Neural stem cell heterogeneity in adult hippocampus.

Liang Z, Jin N, Guo W Cell Regen. 2025; 14(1):6.

PMID: 40053275 PMC: 11889326. DOI: 10.1186/s13619-025-00222-4.


C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury.

Wang X, Niu X, Wang Y, Liu Y, Yang C, Chen X Neural Regen Res. 2024; 20(8):2231-2244.

PMID: 39104168 PMC: 11759034. DOI: 10.4103/NRR.NRR-D-24-00119.

References
1.
Bruno I, Karam R, Huang L, Bhardwaj A, Lou C, Shum E . Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell. 2011; 42(4):500-10. PMC: 3123134. DOI: 10.1016/j.molcel.2011.04.018. View

2.
Fan X, Steitz J . Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 1998; 17(12):3448-60. PMC: 1170681. DOI: 10.1093/emboj/17.12.3448. View

3.
Chen W, Zheng Q, Huang Q, Ma S, Li M . Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease. Elife. 2022; 11. PMC: 9208759. DOI: 10.7554/eLife.75636. View

4.
Yoo A, Sun A, Li L, Shcheglovitov A, Portmann T, Li Y . MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011; 476(7359):228-31. PMC: 3348862. DOI: 10.1038/nature10323. View

5.
Kohn D, Tsai K, Cansino V, Neve R, Perrone-Bizzozero N . Role of highly conserved pyrimidine-rich sequences in the 3' untranslated region of the GAP-43 mRNA in mRNA stability and RNA-protein interactions. Brain Res Mol Brain Res. 1996; 36(2):240-50. DOI: 10.1016/0169-328x(95)00239-o. View